Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of AMDX-2011P in Participants With Alzheimer's Disease

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer's Disease (AD).

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Amydis Inc.Updated: Feb 13, 2026Locations: 1
Eligibility criteria

Confirmed diagnosis of Alzheimer's Disease (AD) with documented positive amyloid... [+2]

Presence of any underlying physical or psychological medical condition that, in... [+4]

Status: Recruiting

A Study of AMDX-2011P in Participants With CAA

The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with cerebral amyloid angiopathy (CAA).

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Amydis Inc.Updated: Feb 13, 2026Locations: 1
Eligibility criteria

Diagnosis of hereditary CAA or probable and definite symptomatic or asymptomatic... [+2]

Presence of any underlying physical or psychological medical condition that, in... [+3]

Status: Recruiting

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).

Participants needed: 50
Trial details
Phase: Phase 2Age: 22+Biological sex: AllType: InterventionalSponsor: Amydis Inc.Updated: Jul 30, 2024Locations: 3
Eligibility criteria

Diagnosis of primary open angle glaucoma in both eyes [+2]

Participants unable to read or write [+2]